Cite
APA Citation
Wei, Y., Wegesser, T., Kuhns, S., Werner, J., Lebrec, H., & Wang, X. (2022). strategies to evaluate potential effector function of glycan variants: a case study of ordesekimab (AMG 714 or PRV-015). Journal of immunotoxicology, 19(1), 109–116. http://access.bl.uk/ark:/81055/vdc_100166773940.0x000019